ScopeBug - Telemedicine Tool Kit

All too often women and babies in underdeveloped countries must risk traveling at great distance to a healthcare provider. Telemedicine is a viable solution. However, doctors need diagnostic tools more precise than the camera and sound from a phone or a computer.

ScopeBug uniquely solves this problem by providing patients with 1) a complete travel size telemedicine kit customizable with the specialized diagnostic tools needed for primary, prenatal, postpartum and infant care, 2) works on any Telehealth platform or services such as Skype or Zoom. 

ScopeBug is less expensive than competitors' products, while allowing for more accurate diagnosis.  Making it easy to connect patients with doctors around the world. This will allow for mother and child to receive care in communities that lack access to quality health services.

If scaled globally, ScopeBug would provide an affordable solution to enable our most vulnerable patients to access medical care anytime and anywhere. 

There is a lack of quality healthcare in developing countries leaving mothers, babies and families at risk.  

Not Enough Doctors: In developing countries quality of prenatal and infant care is often scarce. There are insufficient trained personnel like Pediatricians. For example, in Nigeria, there are only 600 Pediatricians to care for an estimated population of 40 million children. 

Access To Healthcare: Travel time/travel distance to healthcare services impact patients' health outcomes.  Studies have identified evidence of a distance decay association, whereby patients living further away from healthcare facilities they needed to attend had worse health outcomes (eg, survival rates) than those who lived closer. In remote areas and underdeveloped countries the risks are even grater due to limited transportation and violence for this vulnerable population.

High Mortality Rates: The newborn period is the most challenging period of human life and it is the period most susceptible to morbidity and mortality. It is not surprising that the infant mortality rate under five was as high as 124/1000 live births respectively compared to 6/1000 from the USA.

ScopeBug increases access and quality of remote care by providing patients with a complete, easy to use and very affordable portable telemedicine tool kit.  

ScopeBug is lightweight, portable and about the size of a small soft sided first aid kit. It is also customizable with accessories specialized for prenatal and infant care. Basic kits come with an ENT otoscope, stethoscope, calipers and a thermometer. Our prenatal and infant accessories provide special attachments (e.g., Otoscope Cervix Wand, Infant Size ENT Accessories and Otoscope Binky Attachment). 

Our ScopeBug Kit is easy to use and does not require any software or complicated setup. Just simply plug and go by connecting ScopeBug via bluetooth or USB port. 

Now patients can connect with doctors located around the world via a video service like Skype or through an established Telehealth platform. Reducing the need to travel and expanding their access to quality remote care.   

By providing remote or vulnerable communities with ScopeBug kits, we are able to expand access and increase the quality of affordable care to the entire family including women, new mothers and infants. 

Our innovative and interchangeable accessory attachments are designed to address Primary Care, OB-GYN and Pediatric Needs. 

Our easy to use kit increases the chances of early detection, decreasing the risk of spreading diseases between mothers and and newborns. 

We are targeting 3 major market segments to increase the quality of remote healthcare.

NGO - ScopeBug will be sold to NGO's to diagnose and monitor patients.

B2B - ScopeBug can be white labeled to be sold to health insurance companies, Telehealth platforms or clinics to use with their existing telemedicine platforms.

B2C - ScopeBug and accessories will be sold online and stores.

US Telemedicine market is $2.6 billion and projected to reach $25 billion by 2025.

The global market is valued at $25 billion and projected to grow to $55.6 billion by 2025.

90% of large employers offer telemedicine benefits as example Teladoc has over 49 million subscribers.

Most major health insurance plans will offer telemedicine.

ScopeBug increases access to quality remote healthcare that otherwise has not been available.

ScopeBug telemedicine tool kit aligns well with 2 challenges. Health, Security and Pandemics and Maternal and Newborn Health.  

The ScopeBug kit provides the tools doctors need to effectively diagnose patients. Thus expanding access to high-quality, affordable care for everyone, including women, new mothers and babies. 

Using ScopeBug increases the chances of early detection which would decrease the spread of disease and increase the quality of remote care between mothers and and newborns.

Our interchangeable accessory attachments improve gynecological health for all women. 

ScopeBug offers a complete kit that is easy to use, device agnostic and affordable. Our kit comes with accessory attachments that allow for us to also address areas such as pediatrics, dermatology and gynecology. 

In terms of our competition. There are other Telemedicine devices on the market that are either very expensive, not a complete kit or just work with their own platform that require you to use just their doctors. ScopeBug is designed to work with any telemedicine platform or even services such as Skype and does not limit which doctors you can connect with.   

We have created accessories such as a baby binky that attaches to the end of the otoscope so that the doctor can get a clear look into the infants throat. 

We have many more innovative attachments including a wand to check the cervix for dilation in a OB-GYN exam. 

Our core technology is simple. Our otoscope simply connects via bluetooth or plugs in via USB port. It overrides the patients existing camera. The concept is similar to our stethoscope it also connects via bluetooth or will plug in to a mic jack to use the existing audio in conjunction with our analog stethoscope.  

I had created ScopeBug a few years ago and had the occasion to use one of our first prototypes with my son who was home sick with the flu. I decided to record part of the telemedicine visit.  

https://drive.google.com/file/d/1izIu8THVl4TQRDDq9M6f6Q6eNvVfjoIL/view?usp=sharing

We are not on the market yet. So we are not able to serve those in our community yet. 

The first year we are forecasting to serve 500,000 people and by the second year we have forecasted to reach over 1 million. 

ScopeBug will transform million of lives around the world, decrease medical costs, increase access and quality of remote telemedicine care. To achieve these impact goals we have segmented our approach into 3 categories. 

Doctors: There are simply not enough doctors where people need them most. Telemedicine can help healthcare providers reach more patients in one day.  ScopeBug will provide doctors with the tools they need to properly diagnose patients.

ScopeBug will not only allow for an increased quality of healthcare but it will allow for doctors to charge for a slightly higher cost of service than a telemedicine visit without diagnostic equipment. 

Our goal is to reach doctors through clinics, hospitals and Telehealth platforms. Our kit can be white labeled with their logo and branding making it an effective marketing tool that increases business.

Health Insurance Companies: Our goal is to sign licensing or sales agreement with large insurance companies. Providing ScopeBug kits to their members would serve as a great reminder to use their telemedicine services the next time they felt sick. They would save well over $100 per each time a patient chose Telehealth opposed to an in person visit.    

Patients: We are not only able to help patients received an increased quality of remote care via a telemedicine visit, but we are also able to improve their user experience and confidence. We will reach vulnerable and remote patients through NGO or associations like AARP. In addition, we will    

We have a team of 5 people. With 2 people working on this full-time and the rest are part-time. All team members hold an equity position.

Jessica Walsh is a seasoned entrepreneur, Her business and technical experience includes senior management positions in medical device development, technology, business development and team management, Six Sigma process improvements. Founder of Rx Bandz auto- injector and Care2Kids. Inventor of national and international patents. 

Oded Shorer is a multidisciplinary designer, educator, and entrepreneur with more than 15 years of experience bringing products to market. He is the founder of Milestone Studio, a concept to product industrial design consultancy. He serves as a CRIT adviser for Cornell Tech's Startup Studio and as an adviser to numerous accelerator programs in NYC. 

Michael Noonan is a seasoned Wall Street veteran with more than 20 years of experience in sales and trading, having worked both in New York City and London, UK as a Director, and as the Head of Trading at multinational financial institutions. 

Or Ramot has over 20 years of experience in medical device design to manufacturing. Or is a technology team leader in the mechanical, electrical and optical fields. His experience spans from first steps of development such as ideation and prototyping all the way to handling the final technical file and manufacturing site. 

Dr. William Reisacher is an Otolaryngologist/Head and Neck Surgeon with 25 years of experience. Graduated from Cornell University and received his medical degree from The Mount Sinai School of Medicine in NYC. He is a founder, inventor, angel investor and senior advisor for several early- stage companies in the biotechnology, biopharmaceutical, and digital health-tech spaces. 

We have a strategic manufacturing partnership agreement with Kiiam and Milestone Studios. 

Kiiam: A full-service boutique engineering firm with over 30 years of development and production experience. Israel-based with a global network of industry partners, manufacturers and distributors, Kiiam is uniquely positioned to provide the highest quality, turnkey engineering solutions at competitive rates. We design, engineer, prototype, and manufacture products. Kiiam is a one-stop shop for the entire development process - from initial ideas and R&D to production and packaging, we handle it all under one roof. Kii.am is 13485 and 9001 ISO certified. 

Milestone Studios:

Milestone-Studio is a multidisciplinary design studio providing product realization, from concept to production. We combine research, concept development, technology and aesthetics with our engineering and production network, fine-tuned to our client’s needs. Founded in 2009, Milestone-Studio has brought dozens of products to market in a wide range of sectors. 

We are looking at 3 different possible revenue streams.

1. B2B white labeling to large telemedicine platforms, clinics or associations such as AARP. Our device can be white labeled with their logo and would provide their members with an improved user experience in addition to being a physical reminder to user their telemedicine services when feeling sick. Projected Units Sold: 500,000 (year 1) / 1.25M (year 2)/ 2.3M (year 3)

2. B2C selling online and stores is forecasted to start in the second year after the implementation of our marketing campaign. We are projecting sales of 250,000 units (year 2) / 800,000 units (year 3)

3. Selling to NGO’s serving the most vulnerable populations in remote areas. Our plan is to build these relationships as quickly as possible. However, we have been advised that these organizations are often slow to move and we will need to navigate a significant amount of red tape. Therefore we have forecasted sales starting in year 3. Projected Units Sold: 230,000 (year 3) / 800,000 (year 4) / 1.8 (year 5) 

Our financial path to sustainability will be achieved through the following steps.  First we have opened ScopeBug to outside investment. We just recently opened our first round of funding. Due to a high level of interest we anticipate closing the round late August 2020. 

Our second round of funding is forecasted to open in September and close by the end of the year. 

This funding raised in these two rounds will allow for us to take our device from prototype to commercialization within one year. We anticipate sales and to be generating revenue after the first year. 

We are applying to Solve to join your MIT-backed network. Joining your innovation ecosystem would provide the resources, exposure and expertise to scale our work and catapult our business development.

We would welcome your mentorship, strategic advice and possible access to introductions that could evolve into business partnerships.

Our goal is get ScopeBug into the hands of the most vulnerable populations around the world. We would welcome assistance in navigating international agreement with organizations such as the UN, WHO and or NGO's.  

Currently our device and accessory attachments are exempt from premarket notification from the FDA. However some of our future applications may require 510K approval or CE mark. Advice on navigating the pitfalls of international regulatory compliance would always be welcome. 

Our strategy to hit our 1st year revenue goals is to license (white label) or sell our device to large telemedicine companies, health insurance, hospital networks and or other large associations that have millions of users. We would welcome these types of introductions. 

We will also need to build or hire a strong marketing team to achieve our expected B2C revenue goals in the 2nd year. We need to either contract or hire this talent. 

We would like to partner with organizations such as Teledoc, Oscar, Aetna, Blue Cross Blue Shield and AARP. They all have millions of users. ScopeBug could be white labeled with their logo and sent to their members to improve the user experience during a Telemedicine visit.

We would like to partner with IP attorneys or law firms to help us improve upon our IP strategy and grow our IP portfolio.

We would like to partner with a regulatory advisory firm. Our device and the accessory attachments currently are exempt from premarket approval. However, future accessories could be considered class II devices and require a 510K approval.    

ScopeBug provides and innovative technology to improve quality of life for women, girls and families. ScopeBug is a technology-focused projects that advance the needs of women and girls health and access to care they need to survive and thrive. The $75,000 would be used to take our device from prototype to commercialization and into the hands of some of the most vulnerable and remote communities around the world.  

ScopeBug Telemedicine tool kit provides an innovative solution that supports the health of pregnant women, new mothers and infants in low-income countries.

ScopeBug improves quality of care by providing the specialized diagnostic tools healthcare workers need to properly diagnose and treat both mother and child during a telemedicine visit. 

Our travel size kit is inexpensive, easy to use and will work with any platform including services like Skype. Making it easy to connect with doctors around the world. This will allow for mother and child to receive care in communities that lack access to quality health services.

ScopeBug Telemedicine tool kit provides an innovative solution that supports the health of pregnant women, new mothers and infants in low-income countries.

ScopeBug improves quality of care by providing the specialized diagnostic tools healthcare workers need to properly diagnose and treat both mother and child during a telemedicine visit. 

Our travel size kit is inexpensive, easy to use and will work with any platform including services like Skype. Making it easy to connect with doctors around the world. This will allow for mother and child to receive care in communities that lack access to quality health services.

ScopeBug is scalable, for-profit solutions that has the potential to significantly impact millions of lives. Our ScopeBug kit will support the health of pregnant women, new mothers, infants and families around the world and in low-income countries.

ScopeBug improves quality of care by providing the specialized diagnostic tools healthcare workers need to properly diagnose and treat patients during a telemedicine visit. 

Our travel size kit is inexpensive, easy to use and will work with any platform including services like Skype. Making it easy to connect with doctors around the world.